Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Quentin Van Thillo

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Leukemia|January 21, 2025
TLE4 is a repressor of the oncogenic activity of TLX3 in T-cell acute lymphoblastic leukemiaLukas Lauwereins, Quentin Van Thillo, Sofie Demeyer, et al.
Research and Practice in Thrombosis and Haemostasis|April 17, 2025
Clinical utility of panel-based genetic sequencing for von Willebrand diseaseRadha Ramanan, Christine Van Laer, Sarissa Baert, et al.
Blood|August 12, 2022
Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T-cell lymphomaMarlies Vanden Bempt, Koen Debackere, Sofie Demeyer, et al.
Journal of Thrombosis and Haemostasis : JTH|March 6, 2026
Prothrombotic PROC variant rebalancing haemostasis in severe haemophilia A with attenuated bleeding riskRadha Ramanan, Quentin Van Thillo, Renaud Lavend'homme, et al.
Blood|May 29, 2026
Reduced platelet formation associated with serine metabolic dysregulation in integrin αIIbβ3-deficient megakaryocytesKato Ramaekers, My Tran, Marco Lunghi, et al.
Expert Review of Hematology|June 8, 2026
A call to action for the use of composite hematologic measurements in hereditary hemorrhagic telangiectasia and other chronic bleeding disordersHanny Al-Samkari, Raj S Kasthuri, Jenny Y Zhou, et al.
ERJ Open Research|March 2, 2022
Azithromycin for treatment of hospitalised COVID-19 patients: a randomised, multicentre, open-label clinical trial (DAWn-AZITHRO)Iwein Gyselinck, Laurens Liesenborghs, Ann Belmans, et al.
The European Respiratory Journal|August 27, 2021
Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasmaTimothy Devos, Quentin Van Thillo, Veerle Compernolle, et al.
Research and Practice in Thrombosis and Haemostasis|November 3, 2022
Modulation of thromboinflammation in hospitalized COVID-19 patients with aprotinin, low molecular weight heparin, and anakinra: The DAWn-Antico studyMatthias M Engelen, Quentin Van Thillo, Albrecht Betrains, et al.
Nature Communications|July 7, 2021
Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemiaQuentin Van Thillo, Jolien De Bie, Janith A Seneviratne, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Leukemia|January 21, 2025
TLE4 is a repressor of the oncogenic activity of TLX3 in T-cell acute lymphoblastic leukemiaLukas Lauwereins, Quentin Van Thillo, Sofie Demeyer, et al.
Research and Practice in Thrombosis and Haemostasis|April 17, 2025
Clinical utility of panel-based genetic sequencing for von Willebrand diseaseRadha Ramanan, Christine Van Laer, Sarissa Baert, et al.
Blood|August 12, 2022
Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T-cell lymphomaMarlies Vanden Bempt, Koen Debackere, Sofie Demeyer, et al.
Journal of Thrombosis and Haemostasis : JTH|March 6, 2026
Prothrombotic PROC variant rebalancing haemostasis in severe haemophilia A with attenuated bleeding riskRadha Ramanan, Quentin Van Thillo, Renaud Lavend'homme, et al.
Blood|May 29, 2026
Reduced platelet formation associated with serine metabolic dysregulation in integrin αIIbβ3-deficient megakaryocytesKato Ramaekers, My Tran, Marco Lunghi, et al.
Expert Review of Hematology|June 8, 2026
A call to action for the use of composite hematologic measurements in hereditary hemorrhagic telangiectasia and other chronic bleeding disordersHanny Al-Samkari, Raj S Kasthuri, Jenny Y Zhou, et al.
ERJ Open Research|March 2, 2022
Azithromycin for treatment of hospitalised COVID-19 patients: a randomised, multicentre, open-label clinical trial (DAWn-AZITHRO)Iwein Gyselinck, Laurens Liesenborghs, Ann Belmans, et al.
The European Respiratory Journal|August 27, 2021
Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasmaTimothy Devos, Quentin Van Thillo, Veerle Compernolle, et al.
Research and Practice in Thrombosis and Haemostasis|November 3, 2022
Modulation of thromboinflammation in hospitalized COVID-19 patients with aprotinin, low molecular weight heparin, and anakinra: The DAWn-Antico studyMatthias M Engelen, Quentin Van Thillo, Albrecht Betrains, et al.
Nature Communications|July 7, 2021
Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemiaQuentin Van Thillo, Jolien De Bie, Janith A Seneviratne, et al.
Pageof 2